Global and United States Human Low-Pass Whole Genome Sequencing Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States Human Low-Pass Whole Genome Sequencing Market Report & Forecast 2024-2034

Human low-pass whole-genome sequencing is generally defined as sequencing the genome. Combined with genotype imputation, it provides an alternative to genotyping arrays for trait mapping and polygenic score calculations.
Market Analysis and InsightsGlobal and United States Human Low-Pass Whole Genome Sequencing Market
This report focuses on global and United States Human Low-Pass Whole Genome Sequencing market, also covers the segmentation data of other regions in regional level and county level.
The global Human Low-Pass Whole Genome Sequencing revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Human Low-Pass Whole Genome Sequencing revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Human Low-Pass Whole Genome Sequencing include BGI, Breda Genetics, Azenta Life Sciences, Thermo Fisher Scientific, Psomagen, Healgen Scientific, Agilent Technologies, Macrogen and Veritas Genetics, etc. The global five biggest players hold a share of % in 2022.
Global Human Low-Pass Whole Genome Sequencing Scope and Market Size
Human Low-Pass Whole Genome Sequencing market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Human Low-Pass Whole Genome Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Human Low-Pass Whole Genome Sequencing market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.

By Company

BGI
Breda Genetics
Azenta Life Sciences
Thermo Fisher Scientific
Psomagen
Healgen Scientific
Agilent Technologies
Macrogen
Veritas Genetics
Centogene
Nebula Genomics
CD Genomics
Segment by Type
Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)

Segment by Application

Medical
Scientific Research
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction

Chapter 1Introduces Human Low-Pass Whole Genome Sequencing definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Human Low-Pass Whole Genome Sequencing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Human Low-Pass Whole Genome Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Low-Pass Whole Genome Sequencing revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Human Low-Pass Whole Genome Sequencing Product Introduction
1.2 Global Human Low-Pass Whole Genome Sequencing Outlook 2018 VS 2022 VS 2033
1.2.1 Global Human Low-Pass Whole Genome Sequencing Market Size for the Year 2018-2033
1.2.2 United States Human Low-Pass Whole Genome Sequencing Market Size for the Year 2018-2033
1.3 Human Low-Pass Whole Genome Sequencing Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Human Low-Pass Whole Genome Sequencing in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Human Low-Pass Whole Genome Sequencing Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Human Low-Pass Whole Genome Sequencing Market Dynamics
1.4.1 Human Low-Pass Whole Genome Sequencing Industry Trends
1.4.2 Human Low-Pass Whole Genome Sequencing Market Drivers
1.4.3 Human Low-Pass Whole Genome Sequencing Market Challenges
1.4.4 Human Low-Pass Whole Genome Sequencing Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Human Low-Pass Whole Genome Sequencing by Type
2.1 Human Low-Pass Whole Genome Sequencing Market Segment by Type
2.1.1 Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
2.1.2 Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)
2.2 Global Human Low-Pass Whole Genome Sequencing Market Size by Type (2018, 2022 & 2033)
2.3 Global Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2033)
2.4 United States Human Low-Pass Whole Genome Sequencing Market Size by Type (2018, 2022 & 2033)
2.5 United States Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2033)
3 Human Low-Pass Whole Genome Sequencing by Application
3.1 Human Low-Pass Whole Genome Sequencing Market Segment by Application
3.1.1 Medical
3.1.2 Scientific Research
3.1.3 Others
3.2 Global Human Low-Pass Whole Genome Sequencing Market Size by Application (2018, 2022 & 2033)
3.3 Global Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2033)
3.4 United States Human Low-Pass Whole Genome Sequencing Market Size by Application (2018, 2022 & 2033)
3.5 United States Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2033)
4 Global Human Low-Pass Whole Genome Sequencing Competitor Landscape by Company
4.1 Global Human Low-Pass Whole Genome Sequencing Market Size by Company
4.1.1 Global Key Companies of Human Low-Pass Whole Genome Sequencing, Ranked by Revenue (2022)
4.1.2 Global Human Low-Pass Whole Genome Sequencing Revenue by Player (2018-2023)
4.2 Global Human Low-Pass Whole Genome Sequencing Concentration Ratio (CR)
4.2.1 Human Low-Pass Whole Genome Sequencing Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Human Low-Pass Whole Genome Sequencing in 2022
4.2.3 Global Human Low-Pass Whole Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Human Low-Pass Whole Genome Sequencing Head office and Area Served
4.4 Global Key Players of Human Low-Pass Whole Genome Sequencing, Product and Application
4.5 Global Key Players of Human Low-Pass Whole Genome Sequencing, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Human Low-Pass Whole Genome Sequencing Market Size by Company
4.7.1 Key Players of Human Low-Pass Whole Genome Sequencing in United States, Ranked by Revenue (2022)
4.7.2 United States Human Low-Pass Whole Genome Sequencing Revenue by Players (2021, 2022 & 2023)
5 Global Human Low-Pass Whole Genome Sequencing Market Size by Region
5.1 Global Human Low-Pass Whole Genome Sequencing Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2033)
5.2.1 Global Human Low-Pass Whole Genome Sequencing Market Size by Region: 2018-2023
5.2.2 Global Human Low-Pass Whole Genome Sequencing Market Size by Region (2024-2033)
6 Americas
6.1 Americas Human Low-Pass Whole Genome Sequencing Market Size YoY Growth 2018-2033
6.2 Americas Human Low-Pass Whole Genome Sequencing Market Size by Type
6.2.1 Americas Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
6.2.2 Americas Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033)
6.2.3 Americas Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
6.3 Americas Human Low-Pass Whole Genome Sequencing Market Size by Application
6.3.1 Americas Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
6.3.2 Americas Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033)
6.3.3 Americas Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
6.4 Americas Human Low-Pass Whole Genome Sequencing Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Human Low-Pass Whole Genome Sequencing Market Size YoY Growth 2018-2033
7.2 EMEA Human Low-Pass Whole Genome Sequencing Market Size by Type
7.2.1 EMEA Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
7.2.2 EMEA Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033)
7.2.3 EMEA Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
7.3 EMEA Human Low-Pass Whole Genome Sequencing Market Size by Application
7.3.1 EMEA Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
7.3.2 EMEA Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033)
7.3.3 EMEA Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
7.4 EMEA Human Low-Pass Whole Genome Sequencing Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Human Low-Pass Whole Genome Sequencing Market Size YoY Growth 2018-2033
8.2 China Human Low-Pass Whole Genome Sequencing Market Size by Type
8.2.1 China Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
8.2.2 China Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033)
8.2.3 China Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
8.3 China Human Low-Pass Whole Genome Sequencing Market Size by Application
8.3.1 China Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
8.3.2 China Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033)
8.3.3 China Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Human Low-Pass Whole Genome Sequencing Market Size YoY Growth 2018-2033
9.2 APAC Human Low-Pass Whole Genome Sequencing Market Size by Type
9.2.1 APAC Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
9.2.2 APAC Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033)
9.2.3 APAC Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
9.3 APAC Human Low-Pass Whole Genome Sequencing Market Size by Application
9.3.1 APAC Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
9.3.2 APAC Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033)
9.3.3 APAC Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
9.4 APAC Human Low-Pass Whole Genome Sequencing Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 BGI
10.1.1 BGI Company Details
10.1.2 BGI Business Overview
10.1.3 BGI Human Low-Pass Whole Genome Sequencing Introduction
10.1.4 BGI Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.1.5 BGI Recent Development
10.2 Breda Genetics
10.2.1 Breda Genetics Company Details
10.2.2 Breda Genetics Business Overview
10.2.3 Breda Genetics Human Low-Pass Whole Genome Sequencing Introduction
10.2.4 Breda Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.2.5 Breda Genetics Recent Development
10.3 Azenta Life Sciences
10.3.1 Azenta Life Sciences Company Details
10.3.2 Azenta Life Sciences Business Overview
10.3.3 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Introduction
10.3.4 Azenta Life Sciences Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.3.5 Azenta Life Sciences Recent Development
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Company Details
10.4.2 Thermo Fisher Scientific Business Overview
10.4.3 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Introduction
10.4.4 Thermo Fisher Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.4.5 Thermo Fisher Scientific Recent Development
10.5 Psomagen
10.5.1 Psomagen Company Details
10.5.2 Psomagen Business Overview
10.5.3 Psomagen Human Low-Pass Whole Genome Sequencing Introduction
10.5.4 Psomagen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.5.5 Psomagen Recent Development
10.6 Healgen Scientific
10.6.1 Healgen Scientific Company Details
10.6.2 Healgen Scientific Business Overview
10.6.3 Healgen Scientific Human Low-Pass Whole Genome Sequencing Introduction
10.6.4 Healgen Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.6.5 Healgen Scientific Recent Development
10.7 Agilent Technologies
10.7.1 Agilent Technologies Company Details
10.7.2 Agilent Technologies Business Overview
10.7.3 Agilent Technologies Human Low-Pass Whole Genome Sequencing Introduction
10.7.4 Agilent Technologies Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.7.5 Agilent Technologies Recent Development
10.8 Macrogen
10.8.1 Macrogen Company Details
10.8.2 Macrogen Business Overview
10.8.3 Macrogen Human Low-Pass Whole Genome Sequencing Introduction
10.8.4 Macrogen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.8.5 Macrogen Recent Development
10.9 Veritas Genetics
10.9.1 Veritas Genetics Company Details
10.9.2 Veritas Genetics Business Overview
10.9.3 Veritas Genetics Human Low-Pass Whole Genome Sequencing Introduction
10.9.4 Veritas Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.9.5 Veritas Genetics Recent Development
10.10 Centogene
10.10.1 Centogene Company Details
10.10.2 Centogene Business Overview
10.10.3 Centogene Human Low-Pass Whole Genome Sequencing Introduction
10.10.4 Centogene Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.10.5 Centogene Recent Development
10.11 Nebula Genomics
10.11.1 Nebula Genomics Company Details
10.11.2 Nebula Genomics Business Overview
10.11.3 Nebula Genomics Human Low-Pass Whole Genome Sequencing Introduction
10.11.4 Nebula Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.11.5 Nebula Genomics Recent Development
10.12 CD Genomics
10.12.1 CD Genomics Company Details
10.12.2 CD Genomics Business Overview
10.12.3 CD Genomics Human Low-Pass Whole Genome Sequencing Introduction
10.12.4 CD Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
10.12.5 CD Genomics Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Human Low-Pass Whole Genome Sequencing Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Human Low-Pass Whole Genome Sequencing Market Trends
Table 3. Human Low-Pass Whole Genome Sequencing Market Drivers
Table 4. Human Low-Pass Whole Genome Sequencing Market Challenges
Table 5. Human Low-Pass Whole Genome Sequencing Market Restraints
Table 6. Global Human Low-Pass Whole Genome Sequencing Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Human Low-Pass Whole Genome Sequencing Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Human Low-Pass Whole Genome Sequencing Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Human Low-Pass Whole Genome Sequencing Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Human Low-Pass Whole Genome Sequencing, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Human Low-Pass Whole Genome Sequencing Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Human Low-Pass Whole Genome Sequencing Revenue Share by Player, 2018-2023
Table 13. Global Human Low-Pass Whole Genome Sequencing Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Low-Pass Whole Genome Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Low-Pass Whole Genome Sequencing as of 2022)
Table 15. Global Key Players of Human Low-Pass Whole Genome Sequencing, Headquarters and Area Served
Table 16. Global Key Players of Human Low-Pass Whole Genome Sequencing, Product and Application
Table 17. Global Key Players of Human Low-Pass Whole Genome Sequencing, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Human Low-Pass Whole Genome Sequencing in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Human Low-Pass Whole Genome Sequencing Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Human Low-Pass Whole Genome Sequencing Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Human Low-Pass Whole Genome Sequencing Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Human Low-Pass Whole Genome Sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Human Low-Pass Whole Genome Sequencing Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Human Low-Pass Whole Genome Sequencing Market Size by Region (2024-2033) & (US$ Million)
Table 51. BGI Company Details
Table 52. BGI Business Overview
Table 53. BGI Human Low-Pass Whole Genome Sequencing Product
Table 54. BGI Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 55. BGI Recent Development
Table 56. Breda Genetics Company Details
Table 57. Breda Genetics Business Overview
Table 58. Breda Genetics Human Low-Pass Whole Genome Sequencing Product
Table 59. Breda Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 60. Breda Genetics Recent Development
Table 61. Azenta Life Sciences Company Details
Table 62. Azenta Life Sciences Business Overview
Table 63. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product
Table 64. Azenta Life Sciences Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 65. Azenta Life Sciences Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product
Table 69. Thermo Fisher Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Psomagen Company Details
Table 72. Psomagen Business Overview
Table 73. Psomagen Human Low-Pass Whole Genome Sequencing Product
Table 74. Psomagen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 75. Psomagen Recent Development
Table 76. Healgen Scientific Company Details
Table 77. Healgen Scientific Business Overview
Table 78. Healgen Scientific Human Low-Pass Whole Genome Sequencing Product
Table 79. Healgen Scientific Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 80. Healgen Scientific Recent Development
Table 81. Agilent Technologies Company Details
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Human Low-Pass Whole Genome Sequencing Product
Table 84. Agilent Technologies Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 85. Agilent Technologies Recent Development
Table 86. Macrogen Company Details
Table 87. Macrogen Business Overview
Table 88. Macrogen Human Low-Pass Whole Genome Sequencing Product
Table 89. Macrogen Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 90. Macrogen Recent Development
Table 91. Veritas Genetics Company Details
Table 92. Veritas Genetics Business Overview
Table 93. Veritas Genetics Human Low-Pass Whole Genome Sequencing Product
Table 94. Veritas Genetics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 95. Veritas Genetics Recent Development
Table 96. Centogene Company Details
Table 97. Centogene Business Overview
Table 98. Centogene Human Low-Pass Whole Genome Sequencing Product
Table 99. Centogene Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 100. Centogene Recent Development
Table 101. Nebula Genomics Company Details
Table 102. Nebula Genomics Business Overview
Table 103. Nebula Genomics Human Low-Pass Whole Genome Sequencing Product
Table 104. Nebula Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 105. Nebula Genomics Recent Development
Table 106. CD Genomics Company Details
Table 107. CD Genomics Business Overview
Table 108. CD Genomics Human Low-Pass Whole Genome Sequencing Product
Table 109. CD Genomics Revenue in Human Low-Pass Whole Genome Sequencing Business (2018-2023) & (US$ Million)
Table 110. CD Genomics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Low-Pass Whole Genome Sequencing Product Picture
Figure 2. Global Human Low-Pass Whole Genome Sequencing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Human Low-Pass Whole Genome Sequencing Market Size 2018-2033 (US$ Million)
Figure 4. United States Human Low-Pass Whole Genome Sequencing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Human Low-Pass Whole Genome Sequencing Market Size 2018-2033 (US$ Million)
Figure 6. United States Human Low-Pass Whole Genome Sequencing Market Share in Global 2018-2033
Figure 7. Human Low-Pass Whole Genome Sequencing Report Years Considered
Figure 8. Product Picture of Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Figure 9. Product Picture of Small Human Low-Through Whole Genome Sequencing (≤ 5 Mb)
Figure 10. Global Human Low-Pass Whole Genome Sequencing Market Share by Type in 2022 & 2033
Figure 11. Global Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 13. United States Human Low-Pass Whole Genome Sequencing Market Share by Type in 2022 & 2033
Figure 14. United States Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 16. Product Picture of Medical
Figure 17. Product Picture of Scientific Research
Figure 18. Product Picture of Others
Figure 19. Global Human Low-Pass Whole Genome Sequencing Market Share by Application in 2022 & 2033
Figure 20. Global Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2033) & (US$ Million)
Figure 21. Global Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 22. United States Human Low-Pass Whole Genome Sequencing Market Share by Application in 2022 & 2033
Figure 23. United States Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2033) & (US$ Million)
Figure 24. United States Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 25. The Top 5 and 10 Largest Companies of Human Low-Pass Whole Genome Sequencing in the World: Market Share by Human Low-Pass Whole Genome Sequencing Revenue in 2022
Figure 26. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 27. Global Human Low-Pass Whole Genome Sequencing Market Share by Region (2018-2033)
Figure 28. Americas Human Low-Pass Whole Genome Sequencing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 29. Americas Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 30. Americas Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 31. United States Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Canada Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Mexico Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Brazil Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. EMEA Human Low-Pass Whole Genome Sequencing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 36. EMEA Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 37. EMEA Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 38. Europe Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Middle East Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Africa Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Human Low-Pass Whole Genome Sequencing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 42. China Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 43. China Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 44. APAC Human Low-Pass Whole Genome Sequencing Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. APAC Human Low-Pass Whole Genome Sequencing Market Share by Type (2018-2033)
Figure 46. APAC Human Low-Pass Whole Genome Sequencing Market Share by Application (2018-2033)
Figure 47. Japan Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. South Korea Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. China Taiwan Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. India Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. BGI Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 53. Breda Genetics Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 54. Azenta Life Sciences Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 56. Psomagen Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 57. Healgen Scientific Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 58. Agilent Technologies Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 59. Macrogen Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 60. Veritas Genetics Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 61. Centogene Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 62. Nebula Genomics Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 63. CD Genomics Revenue Growth Rate in Human Low-Pass Whole Genome Sequencing Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

A PHP Error was encountered

A PHP Error was encountered

Global and United States Human Low-Pass Whole Genome Sequencing Market Report & Forecast 2024-2034

Global and United States Human Low-Pass Whole Genome Sequencing Market Report & Forecast 2024-2034

By Company

Segment by Application

Chapter Introduction

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries